Search Results
Insilico Announces Preclinical Candidate for Inhalable Formulation of Generative AI IPF Drug
Insilico Medicine's first AI-discovered antifibrotic drug goes first-in-human
Insilico Medicine Initiates Phase 2 Trials for AI Developed IPF Drug
How AI Is Accelerating Drug Discovery
Fireside chat with Michael Levitt: acceleration of AI-powered drug discovery
Legends of Longevity Biotechnology - the 10th ARDD Conference
PandaOmics Generates Dual-Purpose Aging Targets | Aging-US
Quentin Vanhaelen at ARDD2022: Application of PandaOmics for therapeutics D&D for aging and disease
Revolutionizing Biotech R&D with Scispot: Interview with Karthik from Persist AI
